RE:RE:RE:RE:RE:SBOTD: Zacks SCR Initiates Coverage of SBOTD With Buy RecThere is a lot of difference between MX and KHL. Not at present even a comparisson MX has been around since 1968, just short of 50 years. It is 99.15% institutionally owned. Not .08 like KLH
MX pays a 25% dividend. 1 year earnings are +$298 Million KLH -$5.9 M MX is trading at 1.8 x BV The difference in KLH is from BV of $1.56 to current S/P of $11.20.
MX never had to do a share consolidation to raise their S/P
A cheaper method of producing the KLH serum is being worked on world wide. which does not violate any pattents. Like New Zealand where they are injecting Wistar rabbits with the KLH molecule, which reproduces it in about two weeks. The rabbitt is then euthanized and the serum extracted for storage.
China and many other Asian coutries if they see money do not care about US pattents. They may not sell what they make into the US but there is the rest of the world who will buy their cheaper product. Just like genaric drugs.
I'm not saying Stellar cannot succeed. But a simple move to the Nasdaq does not make the company more valuable . They have a lot of work to do yet on their Ballance sheets, and mine fields to navigate.
Just don't get blind folded to the adversities they have yet to overcome. There is no such thing as a sure thing when i comes to investing. Cheers.